RARE buy at 91.87 with profit at $114.84

23 באוג׳ 2020

There has been about a 225% gain since the market bottom to the 5 weeks sideways action on 07/10, which is great action on a stock. During the 5 weeks sideways action there was little volume, which showed that large institutional buyers are not selling and maybe just some mom and pop holders are selling. This makes a great buy at 91.87 assuming the day that it breaks out keeps the price above this metric and has at least 50% above average volume. The reason this is on my screen is because the past 3 quarter had sales of 119,100,156 and not very many stocks has this kind of action. The downside is that this company is not making any money at all so earnings is in the negative. Random news is that on 06/18 Ultragenyx Pharma got FDA approval for Crysvita, which is used to treat Tumor-Induced Osteomalacia. Remember to sell if the price goes 7% below your buy price to reduce risk on your overall portfolio

8 בספט׳ 2020

הפקודה בוטלה

Headed lower never broke out.